(Q50232304)

English

Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial.

scientific article published on 28 July 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27477896

Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27477896

phase III clinical trial

0 references

Crohn's disease

1 reference

based on heuristic

inferred from title

mesenchymal stem cell

1 reference

based on heuristic

inferred from title

7

object named as

Axel Dignass

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

Gert Van Assche

3

object named as

Gert Van Assche

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

Jean-Frédéric Colombel

4

object named as

Jean Frederic Colombel

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27477896

0 references

16

object named as

Silvio Danese

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27477896

Walter Reinisch

5

object named as

Walter Reinisch

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27477896

9

object named as

Marc Ferrante

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27477896

author name string

Julián Panés

1

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27477896

Damián García-Olmo

2

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27477896

Daniel C Baumgart

6

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27477896

Maria Nachury

8

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27477896

Lili Kazemi-Shirazi

10

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27477896

Jean C Grimaud

11

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27477896

Fernando de la Portilla

12

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27477896

Eran Goldin

13

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27477896

Marie Paule Richard

14

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27477896

Anne Leselbaum

15

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27477896

ADMIRE CD Study Group Collaborators

17

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27477896

language of work or name

0 references

publication date

28 July 2016

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27477896

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27477896

388

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27477896

10051

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27477896

1281-1290

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27477896

Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The spectrum of perianal Crohn's disease in a population-based cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathophysiology of fistula formation in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The clinical course of fistulating Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab maintenance therapy for fistulizing Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab for the treatment of fistulas in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical evolution of luminal and perianal Crohn's disease after inducing remission with infliximab: how long should patients be treated?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

6-Mercaptopurine is effective in Crohn's disease without concomitant steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Disappointing durable remission rates in complex Crohn's disease fistula

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Fistulizing Crohn's disease: Diagnosis and management.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Mesenchymal stem cells: mechanisms of inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Mesenchymal stem cells as therapeutic agents of inflammatory and autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Recurrent anal fistulae: limited surgery supported by stem cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Perianal fistulizing Crohn's disease: a call to action.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Adalimumab for the treatment of fistulas in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing the activity of perianal Crohn's disease: comparison of clinical indices and computer-assisted anal ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous adipose tissue-derived stem cells for the treatment of Crohn's fistula: a phase I clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn's fistula

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Review article: The medical treatment of Crohn's perianal fistulas.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931203-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(16)31203-X

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27477896

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27477896

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50232304&oldid=1569437767"